Berthon P - Search Results

1

Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior.

Latil A, Bièche I, Chêne L, Laurendeau I, Berthon P, Cussenot O, Vidaud M. Latil A, et al. Among authors: berthon p. Clin Cancer Res. 2003 Nov 15;9(15):5477-85. Clin Cancer Res. 2003. PMID: 14654526

2

CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.

Latil A, Morant P, Fournier G, Mangin P, Berthon P, Cussenot O. Latil A, et al. Among authors: berthon p. Int J Cancer. 2002 Jun 10;99(5):689-96. doi: 10.1002/ijc.10393. Int J Cancer. 2002. PMID: 12115502

3

Quantification of expression of netrins, slits and their receptors in human prostate tumors.

Latil A, Chêne L, Cochant-Priollet B, Mangin P, Fournier G, Berthon P, Cussenot O. Latil A, et al. Among authors: berthon p. Int J Cancer. 2003 Jan 20;103(3):306-15. doi: 10.1002/ijc.10821. Int J Cancer. 2003. PMID: 12471613

4

Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.

Latil A, Chêne L, Mangin P, Fournier G, Berthon P, Cussenot O. Latil A, et al. Among authors: berthon p. Prostate. 2003 Sep 15;57(1):39-50. doi: 10.1002/pros.10272. Prostate. 2003. PMID: 12886522

5

Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene.

Chêne L, Giroud C, Desgrandchamps F, Boccon-Gibod L, Cussenot O, Berthon P, Latil A. Chêne L, et al. Among authors: berthon p. Int J Cancer. 2004 Sep 20;111(5):798-804. doi: 10.1002/ijc.20337. Int J Cancer. 2004. PMID: 15252854

6

Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

Latil A, Bièche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M. Latil A, et al. Among authors: berthon p. Cancer Res. 2001 Mar 1;61(5):1919-26. Cancer Res. 2001. PMID: 11280747

7

Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.

Naimi B, Latil A, Fournier G, Mangin P, Cussenot O, Berthon P. Naimi B, et al. Among authors: berthon p. Prostate. 2002 Aug 1;52(3):245-52. doi: 10.1002/pros.10104. Prostate. 2002. PMID: 12111699

8

Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.

Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, Berthon P, Cussenot O. Cancel-Tassin G, et al. Among authors: berthon p. Eur Urol. 2003 Oct;44(4):487-90. doi: 10.1016/s0302-2838(03)00319-1. Eur Urol. 2003. PMID: 14499686

9

Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.

Latil AG, Azzouzi R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O. Latil AG, et al. Among authors: berthon pl. Cancer. 2001 Sep 1;92(5):1130-7. doi: 10.1002/1097-0142(20010901)92:5<1130::aid-cncr1430>3.0.co;2-b. Cancer. 2001. PMID: 11571725

10

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer.

Thuret R, Chantrel-Groussard K, Azzouzi AR, Villette JM, Guimard S, Teillac P, Berthon P, Houlgatte A, Latil A, Cussenot O. Thuret R, et al. Among authors: berthon p. Br J Cancer. 2005 Jan 31;92(2):236-40. doi: 10.1038/sj.bjc.6602311. Br J Cancer. 2005. PMID: 15655554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters